{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:52:05Z","timestamp":1784238725898,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Predisposition to mycobacterial infection is a key presenting feature of several rare inborn errors of intrinsic and innate immunity. Hematopoietic stem cell transplantation (HSCT) can be curative for such conditions, but published reports are few. We present a retrospective survey of the outcome of 11 affected patients (7 males, 4 females) who underwent HSCT between 2007 and 2019. Eight patients had disseminated mycobacterial infection prior to transplant. Median age at first transplant was 48\u00a0months (9 -192); three patients were successfully re-transplanted due to secondary graft failure. Donors were matched family (1), matched unrelated (3), and mismatched unrelated and haploidentical family (5 each). Stem cell source was peripheral blood (9), bone marrow (4), and cord blood (1). TCR\u03b1\u03b2\/CD19\u2009+\u2009depletion was performed in 6. Conditioning regimens were treosulfan, fludarabine (4), with additional thiotepa (in 8), and fludarabine, melphalan (2); all had serotherapy with alemtuzumab (8) or anti T-lymphocyte globulin (6). Median hospital stay was 113\u00a0days (36\u2013330). Three patients developed acute grade I-II skin and one grade IV skin graft versus host disease. Four patients had immune-reconstitution syndrome. Two reactivated cytomegalovirus (CMV), 1 Epstein-Barr virus, and 3 adenovirus post HSCT. Nine are alive, 1 died early post-transplant from CMV, and the other was a late death from pneumococcal sepsis. Patients with active mycobacterial infection at HSCT continued anti-mycobacterial therapy for almost 12\u00a0months. In conclusion, HSCT is a successful treatment for patients with mycobacterial susceptibility even with disseminated mycobacterial infection and in the absence of an HLA matched donor.<\/jats:p>","DOI":"10.1007\/s10875-021-01116-1","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T09:02:53Z","timestamp":1628845373000},"page":"1774-1780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Outcome of Hematopoietic Stem Cell Transplantation in patients with Mendelian Susceptibility to Mycobacterial Diseases"],"prefix":"10.1007","volume":"41","author":[{"given":"Nesrine","family":"Radwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Nademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Han","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Flood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Abinun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleri","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Hambleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Slatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"1116_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1146\/annurev.immunol.20.081501.125851","volume":"20","author":"JL Casanova","year":"2002","unstructured":"Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581\u2013620.","journal-title":"Annu Rev Immunol"},{"issue":"8974","key":"1116_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(95)91421-8","volume":"346","author":"JL Casanova","year":"1995","unstructured":"Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A. Immunological conditions of children with BCG disseminated infection. Lancet. 1995;346(8974):581.","journal-title":"Lancet"},{"issue":"3","key":"1116_CR3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1084\/jem.158.3.670","volume":"158","author":"CF Nathan","year":"1983","unstructured":"Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med. 1983;158(3):670\u201389.","journal-title":"J Exp Med"},{"issue":"6\u20137","key":"1116_CR4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00439-020-02120-y","volume":"139","author":"J Bustamante","year":"2020","unstructured":"Bustamante J. Mendelian susceptibility to mycobacterial disease: recent discoveries. Hum Genet. 2020;139(6\u20137):993\u20131000.","journal-title":"Hum Genet"},{"issue":"1","key":"1116_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","volume":"40","author":"A Bousfiha","year":"2020","unstructured":"Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. Human inborn errors of immunity: 2019 update of the IUIS Phenotypical Classification. J Clin Immunol. 2020;40(1):66\u201381.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1116_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","volume":"40","author":"SG Tangye","year":"2020","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human Inborn errors of immunity: 2019 update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40(1):24\u201364.","journal-title":"J Clin Immunol"},{"issue":"4","key":"1116_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s10875-019-00642-3","volume":"39","author":"L Poyhonen","year":"2019","unstructured":"Poyhonen L, Bustamante J, Casanova JL, Jouanguy E, Zhang Q. Life-threatening infections due to live-attenuated vaccines: early manifestations of inborn errors of immunity. J Clin Immunol. 2019;39(4):376\u201390.","journal-title":"J Clin Immunol"},{"issue":"4","key":"1116_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/imcb.12210","volume":"97","author":"J Rosain","year":"2019","unstructured":"Rosain J, Kong XF, Martinez-Barricarte R, Oleaga-Quintas C, Ramirez-Alejo N, Markle J, et al. Mendelian susceptibility to mycobacterial disease: 2014\u20132018 update. Immunol Cell Biol. 2019;97(4):360\u20137.","journal-title":"Immunol Cell Biol"},{"issue":"6","key":"1116_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","volume":"26","author":"J Bustamante","year":"2014","unstructured":"Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin Immunol. 2014;26(6):454\u201370.","journal-title":"Semin Immunol"},{"issue":"5","key":"1116_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10875-018-0527-6","volume":"38","author":"J Rosain","year":"2018","unstructured":"Rosain J, Oleaga-Quintas C, Deswarte C, Verdin H, Marot S, Syridou G, et al. A variety of Alu-mediated copy number variations can underlie IL-12Rbeta1 deficiency. J Clin Immunol. 2018;38(5):617\u201327.","journal-title":"J Clin Immunol"},{"key":"1116_CR11","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.3389\/fimmu.2019.01964","volume":"10","author":"AK Bandari","year":"2019","unstructured":"Bandari AK, Muthusamy B, Bhat S, Govindaraj P, Rajagopalan P, Dalvi A, et al. A novel splice site mutation in IFNGR2 in patients with primary immunodeficiency exhibiting susceptibility to mycobacterial diseases. Front Immunol. 2019;10:1964.","journal-title":"Front Immunol"},{"issue":"23","key":"1116_CR12","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1182\/blood.2019000021","volume":"133","author":"SH Lum","year":"2019","unstructured":"Lum SH, Flood T, Hambleton S, McNaughton P, Watson H, Abinun M, et al. Two decades of excellent transplant survival in children with chronic granulomatous disease. Blood. 2019;133(23):2546\u20139.","journal-title":"Blood"},{"issue":"10","key":"1116_CR13","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1182\/blood.2020005590","volume":"136","author":"R Chiesa","year":"2020","unstructured":"Chiesa R, Wang J, Blok HJ, Hazelaar S, Neven B, Moshous D, et al. Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults. Blood. 2020;136(10):1201\u201311.","journal-title":"Blood"},{"issue":"12","key":"1116_CR14","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1182\/blood-2017-10-811489","volume":"131","author":"E Tholouli","year":"2018","unstructured":"Tholouli E, Sturgess K, Dickinson RE, Gennery A, Cant AJ, Jackson G, et al. In vivo T-depleted reduced intensity transplantation for GATA2-related immune dysfunction. Blood. 2018;131(12):1383\u20137.","journal-title":"Blood"},{"issue":"5","key":"1116_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10875-017-0390-x","volume":"37","author":"E Staples","year":"2017","unstructured":"Staples E, Morillo-Gutierrez B, Davies J, Petersheim D, Massaad M, Slatter M, et al. Disseminated Mycobacterium malmoense and Salmonella infections associated with a novel variant in NFKBIA. J Clin Immunol. 2017;37(5):415\u20138.","journal-title":"J Clin Immunol"},{"issue":"4","key":"1116_CR16","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jaci.2017.07.008","volume":"141","author":"RM Shah","year":"2018","unstructured":"Shah RM, Elfeky R, Nademi Z, Qasim W, Amrolia P, Chiesa R, et al. T-cell receptor \u03b1\u03b2+ and CD19+ cell-depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency. J Allergy Clin Immunol. 2018;141(4):1417\u201326.","journal-title":"J Allergy Clin Immunol"},{"key":"1116_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/pbc.25267","volume":"62","author":"Y Dinur-Schejter","year":"2015","unstructured":"Dinur-Schejter Y, Krauss AC, Erlich O, Gorelik N, Yahel A, Porat I, et al. Bone marrow transplantation for non-malignant diseases using treosulfan-based conditioning. Pediatr Blood Cancer. 2015;62:299\u2013304.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"1116_CR18","doi-asserted-by":"publisher","first-page":"e28187","DOI":"10.1002\/pbc.28187","volume":"67","author":"S Patel","year":"2020","unstructured":"Patel S, Uppuluri R, VellaichamySwaminathan V, Ravichandran N, MelarcodeRamanan K, Raj R. Mendelian susceptibility to mycobacterial disease-challenges in hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2020;67(5):e28187.","journal-title":"Pediatr Blood Cancer."},{"issue":"6","key":"1116_CR19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.jpeds.2004.08.021","volume":"145","author":"J Roesler","year":"2004","unstructured":"Roesler J, Horwitz ME, Picard C, Bordigoni P, Davies G, Koscielniak E, et al. Hematopoietic stem cell transplantation for complete IFN-\u03b3 receptor one deficiency: a multi-institutional survey. J Pediatr. 2004;145(6):806\u201312.","journal-title":"J Pediatr"},{"issue":"1","key":"1116_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/sj.bmt.1705399","volume":"38","author":"CF Chantrain","year":"2006","unstructured":"Chantrain CF, Bruwier A, Brichard B, Largent V, Chapgier A, Feinberg J, et al. Successful hematopoietic stem cell transplantation in a child with active disseminated Mycobacterium fortuitum infection and interferon-gamma receptor 1 deficiency. Bone Marrow Transplant. 2006;38(1):75\u20136.","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"1116_CR21","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1002\/pbc.25625","volume":"62","author":"P Olbrich","year":"2015","unstructured":"Olbrich P, Mart\u00ednez-Saavedra MT, Perez-Hurtado JM, Sanchez C, Sanchez B, Deswarte C, et al. Diagnostic and therapeutic challenges in a child with complete interferon-\u03b3 receptor 1 deficiency. Pediatr Blood Cancer. 2015;62(11):2036\u20139.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1116_CR22","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1371\/journal.pmed.0050026","volume":"5","author":"M Rottman","year":"2008","unstructured":"Rottman M, Soudais C, Vogt G, Renia L, Emile JF, Decaluwe H, et al. IFN-c mediates the rejection of haematopoietic stem cells in IFN-cR1-deficient hosts. PLoS Med. 2008;5(1):e26.","journal-title":"PLoS Med."},{"key":"1116_CR23","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.bbmt.2015.07.008","volume":"21","author":"D Balashov","year":"2015","unstructured":"Balashov D, Shcherbina A, Maschan M, Trakhtman P, Skvortsova Y, Shelikhova L, et al. Single-center experience of unrelated and haploidentical stem cell transplantation with TCR\u03b1\u03b2 and CD19 depletion in children with primary immunodeficiency. Biol Blood Marrow Transplant. 2015;21:1955\u201362.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01116-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-021-01116-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01116-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T04:41:58Z","timestamp":1637383318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-021-01116-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1116"],"URL":"https:\/\/doi.org\/10.1007\/s10875-021-01116-1","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,13]]},"assertion":[{"value":"25 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No formal ethical approval was obtained for this retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Freely given written informed consent was obtained from participants\/parents or legal guardians for data collection and participation as per institutional practice.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Freely given written informed consent was obtained from participants\/parents or legal guardians for publication as per institutional practice.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}